Showing results (821-830 of 1,190) with videos related to

Sort By:
Pageof 119
BMC Pharmacology & Toxicology|August 5, 2025
Integrated multiple machine learning and Mendelian randomization reveal LTF gene as a prognostic biomarker for nonspecific orbital inflammationZixuan Wu, Jinfeng Xu, Yuan Gao, et al.
BMC Pharmacology & Toxicology|October 17, 2025
Kaempferol regulates Ewing sarcoma progression via miR-26b-5p-mediated expression of the family with sequence similarity 98 member AYiquan Ji, Tian Gao, Zehua Xu, et al.
BMC Pharmacology & Toxicology|July 18, 2025
Drug-induced sinusoidal obstruction syndrome: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System (FEARS)Cuicui Sun, Xiaoyan Yang, Lili Wang, et al.
BMC Pharmacology & Toxicology|July 28, 2025
Preclinic evaluation of the safety of potential anticovid-19 phytomedicine: SAYE PLUS impacts on Wistar rat biochemical and histopathological parameters in sub-chronic toxicity studyJoël Ouédraogo, Sylvain Ilboudo, Geoffroy Gueswindé Ouédraogo, et al.
BMC Pharmacology & Toxicology|July 2, 2025
Fosaprepitant for the prevention of multiple-day cisplatin chemotherapy-induced nausea and vomiting: a prospective randomized controlled studyLu Wang, Gaowa Jin, Wenjuan Wang, et al.
BMC Pharmacology & Toxicology|September 20, 2025
Obeticholic acid prevents cyclophosphamide-induced placental injury via SIRT1 and TLR4/NF-κB pathwaysWalaa Yehia Abdelzaher, Hanaa Mohamed Khalaf, Sara M Ahmed, et al.
BMC Pharmacology & Toxicology|June 6, 2025
Effect of adding fenofibrate versus curcumin to glimepiride in patients with type 2 diabetes: a randomized controlled trialEman M Nada, Nashwa M El-Gharbawy, Haidy Abbas, et al.
BMC Pharmacology & Toxicology|February 23, 2024
The effect of oral supplementation of Paricalcitol on C-reactive protein levels in chronic kidney disease patients: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trialsSeyyed Mostafa Arabi, Mostafa Shahraki-Jazinaki, Mahla Chambari, et al.
BMC Pharmacology & Toxicology|March 5, 2024
Risk of CKD among patients with DM taking diuretics or SGLT2i: a retrospective cohort study in TaiwanHan-Jie Lin, Pin-Yang Shih, Stella Chin-Shaw Tsai, et al.
BMC Pharmacology & Toxicology|February 23, 2024
Pharmacovigilance study of BCR-ABL1 tyrosine kinase inhibitors: a safety analysis of the FDA adverse event reporting systemDehua Zhao, Xiaoqing Long, Jisheng Wang
Pageof 119